HyClone reduced-serum media

Friday, 15 August, 2014 | Supplied by: In Vitro Technologies Pty Ltd


A viable alternative to classical media supplemented with 10% FBS is reduced-serum media formulations. These formulations of classical media types, such as DMEM and RPMI, are nutritionally enhanced using the natural components of serum, including lipids, growth factors and proteins, which allow the use of serum to be reduced as low as 2% depending on cell type. Additionally, the reduced serum content in a user’s media helps to reduce any variability in their cell culture due to variability in serum batches, enabling a more flexible process.

The HyClone range of reduced-serum media, along with the full HyClone portfolio of media, serum, buffers and process supplements, is distributed in Australia by In Vitro Technologies. The company provides full product support for the range including serum batch testing support and media customisation.

Online: www.invitro.com.au
Phone: 03 9771 3700
Related Products

EpigenTek EpiQuik CUT&RUN m6A RNA Enrichment (MeRIP) Kit

The kit is a complete set of optimised buffers and reagents designed to enrich an RNA fragment...

Cayman Chemical Off-Patent Drug Screening Library (96-Well)

Featuring a curated collection of FDA-approved compounds that are no longer covered under...

Norgen Biotek Bacterial EV Isolation Kit

The Bacterial EV Isolation Kit enables researchers to isolate extracellular vesicles directly...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd